Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Sedation in Hysteroscopy
NCT07076628Phase 4Completed
- Sponsor
- Dongguk University
- Start
- Aug 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in hysteroscopic surgery (2 arms), sponsored by Dongguk University. Primary endpoints: Respiratory insufficiency before surgery up to 30 minutes and Respiratory insufficiency during surgery up to 60 minutes. Started Aug 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
hysteroscopic surgery
Beyond the preview
Go deeper on NCT07076628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07076628.